United States Microbiology Market Report 2019: Forecast Volumes and Sales for Over 100 Infectious Disease Tests - ResearchAndMarkets.com

The "2019
US Microbiology Market Shares, Segmentation Forecasts, Competitive
Landscape, Innovative Technologies, Latest Instrumentation,
Opportunities for Suppliers" report has been added to ResearchAndMarkets.com's
offering.

The report presents a new strategic analysis of major business
opportunities emerging in the infectious disease testing market during
the next five years. The report examines key US market trends; reviews
current and emerging assays; analyzes potential applications of
innovative diagnostic Technologies; forecasts volume and sales for over
100 infectious disease tests by assay, and market segment; provides test
volume estimates by method (molecular, serology/immunodiagnostics,
culture/microscopy); profiles leading players and potential market
entrants; and suggests alternative business expansion strategies for
suppliers.

Rationale

This comprehensive report will assist diagnostics industry executives,
as well as companies planning to diversify into the dynamic and rapidly
expanding microbiology testing market, in evaluating emerging
opportunities and developing effective business strategies. Microbiology
testing is one of the most rapidly growing segments of the in vitro
diagnostics industry, and the greatest challenge facing suppliers during
this decade.

Among the main driving forces is continuing spread of AIDS, which
remains the worlds major health threat and a key factor contributing to
the rise of opportunistic infections; threat of bioterrorism; advances
in molecular diagnostic Technologies; and a wider availability of
immunosuppressive drugs.

Although for some infections the etiology is still a mystery, while for
others the causative microorganisms are present in minute concentrations
long before the occurrence of first clinical symptoms, recent advances
in genetic engineering and detection technologies are creating exciting
opportunities for highly sensitive, specific and cost-effective products.

Opportunities and Strategic Recommendations

• Emerging opportunities for new instrumentation, reagents kits, IT and
  other products with significant market appeal during the next five
  years.
• Design criteria for decentralized testing products.
• Alternative market penetration strategies.
• Potential market entry barriers and risks.

Infectious Diseases Analyzed in the Report

AIDS/HIV, Adenovirus, Aeromonads, Bartonella, Blastocystis Hominis,
Campylobacter, Candida, Chancroid, Chlamydia, Clostridium, Coronavirus,
Coxsackievirus, Cryptosporidium, Cyclospora, CMV, E. Coli, Echovirus,
Encephalitis, Enterovirus, EBV, Giardia, Gonorrhea, Granuloma Inguinale,
Hantavirus, H. Pylori, Hepatitis, Herpes Influenza, Legionella, Lyme
disease, Lymphogranuloma, Malaria, Measles, Meningitis, Microsporidium,
Mononucleosis, Mumps, Mycoplasma, HPV, Parvovirus, Pneumonia,
Polyomaviruses, Pseudomonas, Rabies, RSV, Rhinovirus, Rotavirus ,
Rubella, Salmonella, Septicemia, Shigella, Staphylococci, Streptococci,
Syphilis, Toxoplasmosis, Trichomonas, TB, Vibrio, West Nile, Yersinia.

Market Segmentation Analysis

• Sales and market shares of major suppliers by individual test.
• Volume and sales forecasts for over 100 infectious disease assays by
  individual test and market segment:
• Hospitals
• Blood Banks
• Commercial/Private Laboratories
• Physician Offices/Group Practices
• Public Health Laboratories
• Test volume estimates by method (molecular,
  serology/immunodiagnostics, culture/microscopy).
• Review of the market dynamics, trends, structure, size, growth and
  major suppliers.

Current and Emerging Products

• In-depth examination of over 100 major diseases, including their
  etiology, current diagnostic tests, vaccines, drugs and market needs.
• Review of major analyzers used for infectious disease testing,
  including their operating characteristics, features and selling prices.

Technology Review

• Assessment of molecular diagnostic, monoclonal antibody, immunoassay,
  and other Technologies and their potential applications for infectious
  disease testing.
• Global listings of companies developing or marketing infectious
  disease diagnostic products by individual test.

Competitive Assessments

• Strategic assessments of major suppliers and emerging market entrants,
  including their sales, product portfolios, marketing tactics,
  collaborative arrangements and new products in R&D.

Companies Mentioned

• Abbott
• Affymetrix
• Beckman Coulter/Danaher
• Becton Dickinson
• bioMerieux
• Bio-Rad
• Cepheid
• Diamedix
• DiaSorin
• Eiken Chemical
• Elitech Group
• Enzo Biochem
• Fujirebio
• Grifols
• GSK Biologicals
• Hologic
• Leica Biosystems
• Lonza
• Ortho-Clinical Diagnostics
• PerkinElmer
• Qiagen
• Roche
• Scienion
• Sequenom
• SeraCare
• Siemens Healthineers
• Takara Bio
• Thermo Fisher
• Wako

For more information about this report visit https://www.researchandmarkets.com/r/wni8td

View source version on businesswire.com: https://www.businesswire.com/news/home/20190425005620/en/